financetom
Business
financetom
/
Business
/
Kailera Therapeutics files for US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kailera Therapeutics files for US IPO
Mar 27, 2026 1:32 PM

March 27 (Reuters) - Kailera Therapeutics has filed for

a U.S. initial public offering, the company said in a filing on

Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Microsoft-backed OpenAI Attracting Nvidia, Apple in $6.5 Billion Funding Round, Reuters Says
Market Chatter: Microsoft-backed OpenAI Attracting Nvidia, Apple in $6.5 Billion Funding Round, Reuters Says
Sep 16, 2024
05:11 AM EDT, 09/16/2024 (MT Newswires) -- Microsoft ( MSFT ) -back OpenAI is drawing interest from new investors Nvidia ( NVDA ) and Apple ( AAPL ) in a $6.5 billion round of financing that aims to value the generative artificial intelligence firm at $150 billion, Reuters reported Friday, citing unnamed sources with direct knowledge of the matter. Sequoia...
AstraZeneca's Trial Shows IMFINZI Reduces Risk of Recurrence, Death in Patients With Bladder Cancer
AstraZeneca's Trial Shows IMFINZI Reduces Risk of Recurrence, Death in Patients With Bladder Cancer
Sep 16, 2024
04:33 AM EDT, 09/16/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Sunday that results from its NIAGARA phase III trial showed IMFINZI in combination with chemotherapy has a statistically significant and clinically meaningful improvement in event-free survival and overall survival versus neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer. Patients treated with the IMFINZI perioperative regimen had a 32%...
Genmab Reports 'Encouraging' Data From Phase 1/2 Study of Investigational Ovarian Cancer Drug
Genmab Reports 'Encouraging' Data From Phase 1/2 Study of Investigational Ovarian Cancer Drug
Sep 16, 2024
05:08 AM EDT, 09/16/2024 (MT Newswires) -- Genmab ( GMAB ) said Sunday new data from an ongoing phase 1/2 study of rinatabart sesutecan, or Rina-S, showed an encouraging response rate in heavily pretreated patients with ovarian cancer. The data is from the dose expansion part of the study, which is evaluating Rina-S in ovarian cancer and endometrial cancer. The...
Walt Disney, DirecTV Strike Agreement in Principle to Restore Content
Walt Disney, DirecTV Strike Agreement in Principle to Restore Content
Sep 16, 2024
05:58 AM EDT, 09/16/2024 (MT Newswires) -- Walt Disney ( DIS ) and DirecTV said Saturday they have reached an agreement in principle to restore Disney ( DIS ) content to DirecTV. Disney ( DIS ) halted distribution of its content to DirecTV over stalled negotiations. Though it has restored service, the two companies are still trying to finalize a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved